Recent advances in understanding and diagnosing hepatitis B virus infection.

Slim FOURATI, Jean-Michel PAWLOTSKY,

F1000Res. 06/09/2016;5 : REV-2243 10.12688/f1000research.8983.1

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens.

B Maasoumy, J Vermehren, MW Welker, B Bremer, D Perner, C Honer Zu Siederdissen, K Deterding, P Lehmann, G Cloherty, B Reinhardt, Jean-Michel PAWLOTSKY, MP Manns, S Zeuzem, M Cornberg, H Wedemeyer, C Sarrazin,

J Hepatol. 01/09/2016;65(3) : 473-482 10.1016/j.jhep.2016.04.006. 13/04/2016

Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens.

Jean-Michel PAWLOTSKY,

Gastroenterology 01/07/2016;151(1) : 70-86 10.1053/j.gastro.2016.04.003 11/04/2016

The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway.

T Denaes, J Lodder, MN Chobert, Isaac RUIZ, Jean-Michel PAWLOTSKY, S Lotersztajn, Fatima TEIXEIRA-CLERC,

Sci Rep. 27/06/2016;6 : 28806 10.1038/srep28806.

New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.

A Meguellati, Abdelhakim AHMED-BELKACEM, A Nurisso, W Yi, Rozenn BRILLET, N Berqouch, L Chavoutier, A Fortune, Jean-Michel PAWLOTSKY, A Boumendjel, M Peuchmaur,

Eur J Med Chem. 10/06/2016;115 : 217-229 10.1016/j.ejmech.2016.03.005. 10/03/2016

Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen.

Christophe HEZODE, Stephane CHEVALIEZ, G Scoazec, Alexandre SOULIER, A Varaut, Magali BOUVIER-ALIAS, Isaac RUIZ, F Roudot-Thoraval, A Mallat, Cyrille FERAY, Jean-Michel PAWLOTSKY,

Hepatology 01/06/2016;63(6) : 1809-1816 10.1002/hep.28491 10/03/2016

Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

J Vermehren, B Maasoumy, R Maan, G Cloherty, C Berkowski, JJ Feld, M Cornberg, Jean-Michel PAWLOTSKY, S Zeuzem, MP Manns, C Sarrazin, H Wedemeyer,

Clin Infect Dis. 15/05/2016;62(10) : 1228-1234 10.1093/cid/ciw061 09/02/2016

Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care.

Stephane CHEVALIEZ, Lila POITEAU, I Rosa, Alexandre SOULIER, F Roudot-Thoraval, S Laperche, Christophe HEZODE, Jean-Michel PAWLOTSKY,

Clin Microbiol Infect. 01/05/2016;22(5) : 459.e1-6 10.1016/j.cmi.2016.01.009. 22/01/2016

Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots.

Lila POITEAU, Alexandre SOULIER, I Rosa, F Roudot-Thoraval, Christophe HEZODE, Jean-Michel PAWLOTSKY, Stephane CHEVALIEZ,

J Viral Hepat. 01/05/2016;23(5) : 399-401 10.1111/jvh.12501 01/02/2016

Multicenter clinical evaluation of the new 3rd generation assay for detection of antibodies against hepatitis C virus on the VIDAS(®) system.

B Seigneres, F Descamps, R Croise, V Barlet, Magali BOUVIER-ALIAS, Stephane CHEVALIEZ, Jean-Michel PAWLOTSKY, W Abdelhady, M Rafik, AM Avellon, JM Echevarria, M Hausmann, JM Dugua,

J Clin Virol. 01/05/2016;78 : 20-26 10.1016/j.jcv.2016.03.001. 04/03/2016